Concepedia

Emmalyn Chen

EC

Statistics

Publications

7

Citations

161

H-Index

7

Active since

2020

Affiliations

University of California, San Francisco(Current)

Case Western Reserve University

Stanford University

Duke Cancer Institute

University of Maryland, Baltimore

Emmalyn Chen is an author at University of California, San Francisco specializing in medicine, oncology, and computational pathology.

ORCID

Top concepts

Publications per year

2020–2025

7

Publications

7

Cell-free DNA concentration and fragment size as a biomarker for prostate cancer

Emmalyn Chen, Clinton L. Cario, Lancelote Leong et al. · Scientific Reports · 2021 · 75 citations · Full text

A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer

Clinton L. Cario, Emmalyn Chen, Lancelote Leong et al. · BMC Cancer · 2020 · 20 citations · Full text

Leveraging sequences missing from the human genome to diagnose cancer

Ilias Georgakopoulos‐Soares, Ofer Yizhar Barnea, Ioannis Mouratidis et al. · 2021 · 17 citations · Full text

, , +21

An AI-derived digital pathology-based biomarker to predict the benefit of androgen deprivation therapy in localized prostate cancer with validation in NRG/RTOG 9408.

Daniel E. Spratt, Yilun Sun, Douwe Van der Wal et al. · Journal of Clinical Oncology · 2022 · 15 citations

, , +23

Development and validation of an AI-derived digital pathology-based biomarker to predict benefit of long-term androgen deprivation therapy with radiotherapy in men with localized high-risk prostate cancer across multiple phase III NRG/RTOG trials.

Andrew J. Armstrong, Vinnie YT Liu, Ramprasaath R. Selvaraju et al. · Journal of Clinical Oncology · 2023 · 13 citations

, , +14

1–5 of 7